Ultragenyx Pharmaceutical Inc. Provides Revenue Guidance for the Year 2022 and 2023
For the year 2022, the company expects total product revenue of $352 million to $356 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
43.69 USD | +3.12% | +1.91% | -8.64% |
1st Jan change | Capi. | |
---|---|---|
-8.64% | 3.6B | |
+2.49% | 96.73B | |
-0.49% | 21.31B | |
-16.61% | 21.21B | |
-5.29% | 18.79B | |
-42.14% | 16.37B | |
-27.40% | 13.68B | |
+1.44% | 13.44B | |
+21.29% | 10.98B | |
-21.79% | 8.56B |